Advisory for fungal drugs.
D000284:Administration, Oral; D000935:Antifungal Agents / Q000008:administration & dosage / Q000009:adverse effects*; D004348:Drug Labeling; D006333:Heart Failure / Q000139:chemically induced; D006801:Humans; D017964:Itraconazole / Q000008:administration & dosage / Q000009:adverse effects*; D017093:Liver Failure / Q000139:chemically induced; D009281:Naphthalenes / Q000008:administration & dosage / Q000009:adverse effects*; D013607:Tablets; D000077291:Terbinafine; D014481:United States; D014486:United States Food and Drug Administration
D000935:Antifungal Agents; D009281:Naphthalenes; D013607:Tablets; D017964:Itraconazole; D000077291:Terbinafine